Maxim downgraded BrainStorm (BCLI) to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCLI:
- Brainstorm Cell Therapeutics Faces Nasdaq Delisting Notice
- BrainStorm announces Nasdaq delisting and transition to OTCQB
- Brainstorm Cell Therapeutics Approves Stock Plan Amendments
- BrainStorm files to sell 2.76M shares of common stock for holders
- Promising Survival Data and Regulatory Progress Bolster Buy Rating for Brainstorm Cell Therapeutics